|
1
|
Dicken BJ, Bigam DL, Cass C, Mackey JR,
Joy AA and Hamilton SM: Gastric adenocarcinoma: review and
considerations for future directions. Ann Surg. 241:27–39.
2005.PubMed/NCBI
|
|
2
|
Sapari NS, Loh M, Vaithilingam A and Soong
R: Clinical potential of DNA methylation in gastric cancer: a
meta-analysis. PLoS One. 7:e362752012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shin A, Kim J and Park S: Gastric cancer
epidemiology in Korea. J Gastric Cancer. 11:135–140. 2011.
View Article : Google Scholar
|
|
4
|
Inoue M and Tsugane S: Epidemiology of
gastric cancer in Japan. Postgrad Med J. 81:419–424. 2005.
View Article : Google Scholar
|
|
5
|
Yasui W, Oue N, Aung PP, Matsumura S,
Shutoh M and Nakayama H: Molecular-pathological prognostic factors
of gastric cancer: a review. Gastric Cancer. 8:86–94. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lauren P: The two histological main types
of gastric carcinoma: diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965.PubMed/NCBI
|
|
7
|
Tan IB, Ivanova T, Lim KH, et al:
Intrinsic subtypes of gastric cancer, based on gene expression
pattern, predict survival and respond differently to chemotherapy.
Gastroenterology. 141:476–485. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng HC, Li XH, Hara T, et al: Mixed-type
gastric carcinomas exhibit more aggressive features and indicate
the histogenesis of carcinomas. Virchows Arch. 452:525–534. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ackerman LV and Rosai J: Rosai and
Ackerman’s Surgical Pathology. 9th edition. Mosby; St. Louis, MO:
2004
|
|
10
|
Bosman FT; World Health Organization
International Agency for Research on Cancer. WHO Classification of
Tumors of the Digestive System. International Agency for Research
on Cancer. 4th edition. IARC Press; Lyon: 2010
|
|
11
|
Oue N, Mitani Y, Motoshita J, et al:
Accumulation of DNA methylation is associated with tumor stage in
gastric cancer. Cancer. 106:1250–1259. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamamoto E, Suzuki H, Takamaru H, Yamamoto
H, Toyota M and Shinomura Y: Role of DNA methylation in the
development of diffuse-type gastric cancer. Digestion. 83:241–249.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Choi J, Cho MY, Jung SY, Jan KM and Kim
HS: CpG island methylation according to the histologic patterns of
early gastric adenocarcinoma. Korean J Pathol. 45:469–476. 2011.
View Article : Google Scholar
|
|
14
|
Dedeurwaerder S, Defrance M, Calonne E,
Denis H, Sotiriou C and Fuks F: Evaluation of the Infinium
Methylation 450K technology. Epigenomics. 3:771–784. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hong SJ, Kang MI, Oh JH, et al: DNA
methylation and expression patterns of key tissue-specific genes in
adult stem cells and stomach tissues. J Korean Med Sci. 24:918–929.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao C and Bu X: Promoter methylation of
tumor-related genes in gastric carcinogenesis. Histol Histopathol.
27:1271–1282. 2012.PubMed/NCBI
|
|
17
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.
|
|
18
|
Dittmer J: The biology of the Ets1
proto-oncogene. Mol Cancer. 2:292003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsutsumi S, Kuwano H, Nagashima N, Shimura
T, Mochiki E and Asao T: Ets-1 expression in gastric cancer.
Hepatogastroenterology. 52:654–656. 2005.PubMed/NCBI
|
|
20
|
Yu Y, Zhang YC, Zhang WZ, et al: Ets1 as a
marker of malignant potential in gastric carcinoma. World J
Gastroenterol. 9:2154–2159. 2003.PubMed/NCBI
|
|
21
|
Lind GE, Danielsen SA, Ahlquist T, et al:
Identification of an epigenetic biomarker panel with high
sensitivity and specificity for colorectal cancer and adenomas. Mol
Cancer. 10:852011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oster B, Thorsen K, Lamy P, et al:
Identification and validation of highly frequent CpG island
hypermethylation in colorectal adenomas and carcinomas. Int J
Cancer. 129:2855–2866. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chandrasekaran EV, Lakhaman SS, Chawda R,
Piskorz CF, Neelamegham S and Matta KL: Identification of
physiologically relevant substrates for cloned Gal:
3-O-sulfotransferases (Gal3STs): distinct high affinity of
Gal3ST-2 and LS180 sulfotransferase for the globo H backbone,
Gal3ST-3 for N-glycan multiterminal Galβ1, 4GlcNAcβ units
and 6-sulfoGalβ1, 4GlcNAcβ, and Gal3ST-4 for the mucin core-2
trisaccharide. J Biol Chem. 279:10032–10041. 2004.PubMed/NCBI
|
|
24
|
Seko A, Nagata K, Yonezawa S and Yamashita
K: Down-regulation of Gal 3-O-sulfotransferase-2 (Gal3ST-2)
expression in human colonic non-mucinous adenocarcinoma. Jpn J
Cancer Res. 93:507–515. 2002.
|
|
25
|
Shi BZ, Hu P, Geng F, He PJ and Wu XZ:
Gal3ST-2 involved in tumor metastasis process by regulation of
adhesion ability to selectins and expression of integrins. Biochem
Biophys Res Commun. 332:934–940. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheong TC, Shin JY and Chun KH: Silencing
of galectin-3 changes the gene expression and augments the
sensitivity of gastric cancer cells to chemotherapeutic agents.
Cancer Sci. 101:94–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim SJ, Choi IJ, Cheong TC, et al:
Galectin-3 increases gastric cancer cell motility by up-regulating
fascin-1 expression. Gastroenterology. 138:1035–1045. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim SJ, Shin JY, Lee KD, et al: Galectin-3
facilitates cell motility in gastric cancer by up-regulating
protease-activated receptor-1 (PAR-1) and matrix
metalloproteinase-1 (MMP-1). PLoS One. 6:e251032011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kwak JE, Kim HS, Joo M, Chang SH, Shim SH
and Lee HR: The expression of galectin-3 and galectin-7 in
epithelial dysplasia and adenocarcinoma of the stomach. Korean J
Pathol. 42:365–372. 2008.
|
|
30
|
Saito Y, Sekine W, Sano R, et al:
Potentiation of cell invasion and matrix metalloproteinase
production by α3β1 integrin-mediated adhesion of gastric carcinoma
cells to laminin-5. Clin Exp Metastasis. 27:197–205. 2010.
|
|
31
|
Takatsuki H, Komatsu S, Sano R, Takada Y
and Tsuji T: Adhesion of gastric carcinoma cells to peritoneum
mediated by α3β1 integrin (VLA-3). Cancer Res. 64:6065–6070.
2004.
|
|
32
|
Ura H, Denno R, Hirata K, Yamaguchi K and
Yasoshima T: Separate functions of α2β1 and α3β1 integrins in the
metastatic process of human gastric carcinoma. Surg Today.
28:1001–1006. 1998.
|
|
33
|
Adachi M, Taki T, Huang C, et al: Reduced
integrin alpha3 expression as a factor of poor prognosis of
patients with adenocarcinoma of the lung. J Clin Oncol.
16:1060–1067. 1998.PubMed/NCBI
|
|
34
|
Hashida H, Takabayashi A, Tokuhara T, et
al: Integrin α3 expression as a prognostic factor in colon cancer:
association with MRP-1/CD9 and KAI1/CD82. Int J Cancer. 97:518–525.
2002.
|
|
35
|
Kurokawa A, Nagata M, Kitamura N, et al:
Diagnostic value of integrin α3, β4, and β5 gene expression levels
for the clinical outcome of tongue squamous cell carcinoma. Cancer.
112:1272–1281. 2008.
|
|
36
|
Zhu GH, Huang C, Qiu ZJ, et al: Expression
and prognostic significance of CD151, c-Met, and integrin
alpha3/alpha6 in pancreatic ductal adenocarcinoma. Dig Dis Sci.
56:1090–1098. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Park SY, Kook MC, Kim YW, Cho NY, Kim TY
and Kang GH: Mixed-type gastric cancer and its association with
high-frequency CpG island hypermethylation. Virchows Arch.
456:625–633. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Alves MK, Ferrasi AC, Lima VP, Ferreira
MV, de Moura Campos Pardini MI and Rabenhorst SH: Inactivation of
COX-2, HMLH1 and CDKN2A genes by promoter
methylation in gastric cancer: relationship with histological
subtype, tumor location and Helicobacter pylori genotype.
Pathobiology. 78:266–276. 2011.
|
|
39
|
Alves MK, Lima VP, Ferrasi AC, Rodrigues
MA, De Moura Campos Pardini MI and Rabenhorst SH: CDKN2A
promoter methylation is related to the tumor location and
histological subtype and associated with Helicobacter pylori
flaA(+) strains in gastric adenocarcinomas. APMIS. 118:297–307.
2010. View Article : Google Scholar
|
|
40
|
Dong CX, Deng DJ, Pan KF, et al: Promoter
methylation of p16 associated with Helicobacter
pylori infection in precancerous gastric lesions: a
population-based study. Int J Cancer. 124:434–439. 2009.
|
|
41
|
Kang GH, Lee S, Cho NY, et al: DNA
methylation profiles of gastric carcinoma characterized by
quantitative DNA methylation analysis. Lab Invest. 88:161–170.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Maekita T, Nakazawa K, Mihara M, et al:
High levels of aberrant DNA methylation in Helicobacter
pylori-infected gastric mucosae and its possible association
with gastric cancer risk. Clin Cancer Res. 12:989–995.
2006.PubMed/NCBI
|
|
43
|
Peterson AJ, Menheniott TR, O’Connor L, et
al: Helicobacter pylori infection promotes methylation and
silencing of trefoil factor 2, leading to gastric tumor
development in mice and humans. Gastroenterology. 139:2005–2017.
2010. View Article : Google Scholar
|
|
44
|
Essner JJ, Chen E and Ekker SC:
Syndecan-2. Int J Biochem Cell Biol. 38:152–156. 2006. View Article : Google Scholar
|
|
45
|
Han I, Park H and Oh ES: New insights into
syndecan-2 expression and tumourigenic activity in colon carcinoma
cells. J Mol Histol. 35:319–326. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bai F, Guo X, Yang L, et al: Establishment
and characterization of a high metastatic potential in the
peritoneum for human gastric cancer by orthotopic tumor cell
implantation. Dig Dis Sci. 52:1571–1578. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Budarf ML, Goyette P, Boucher G, et al: A
targeted association study in systemic lupus erythematosus
identifies multiple susceptibility alleles. Genes Immun. 12:51–58.
2011. View Article : Google Scholar : PubMed/NCBI
|
